The hair is not being taken by the drug

It is real, it is in the trial data, and it is not the drug doing it. All three of those things are true at once, and the third one is the one that decides what you should do about it.

In the Wegovy weight-management trial, alopecia was reported by 3.3 percent of people on semaglutide against 1.4 percent on placebo. Relative risk 2.38. Not enormous in absolute terms, and not nothing either.

Then there is the number underneath it, and it settles the argument.

Same drug, same dose, different outcome

Inside that trial, the people who lost more than 20 percent of their bodyweight reported hair loss at 5.3 percent. The people who lost less than 20 percent reported it at 2.5 percent.

Read that again. Same molecule. Same injections. Roughly double the rate of shedding in the group that lost more weight.

If semaglutide attacked hair follicles directly, the rate would track the dose. It tracks the weight loss instead. The systematic review of this literature reaches the same conclusion from a different angle: tirzepatide, which produces the largest weight loss of any of them, is the one most frequently linked to telogen effluvium, while the older and weaker agents like liraglutide and exenatide carry lower reported risk.

What you are looking at is not a side effect of a drug. It is a side effect of losing weight fast, and the drug's only role is making that easy.

What telogen effluvium actually is

A hair follicle spends years in its growing phase, then a short resting phase, then sheds. At any moment most of your head is growing and a small minority is resting, which is why normal shedding goes unnoticed.

A large physiological shock pushes an abnormal share of follicles into the resting phase all at once. Fever does it. Surgery does it. Childbirth does it. A rapid, substantial drop in bodyweight does it.

The follicles do not shed immediately. They sit in the resting phase for a couple of months and then release together, which is why the bathroom floor looks catastrophic on a single morning several months after the thing that caused it.

That delay is the cruellest part of the whole business. By the time the hair comes out, the person is usually feeling better than they have in years, and the shedding arrives with no obvious cause attached to it.

The timeline, which is the thing people actually want

• Trigger to shedding: generally two to three months, sometimes stretching to six from the start of treatment.
• Shedding to recovery: improvement usually begins within three to six months of the trigger being removed, with resolution typically inside six to twelve months as weight stabilises.
• Regrowth visible: later than that again, because new hair has to grow from the follicle at roughly a centimetre a month.

There is no overnight version of this. The query exists, people type it, and the honest answer is that hair grows on a schedule the body set long before you were consulted. Anything promising otherwise is selling something.

What the diet is actually doing

Here is where this stops being dermatology and becomes my problem.

The follicle is one of the most metabolically demanding structures in the body. It divides constantly, it is not required for survival, and when the body starts rationing, it is near the front of the queue to be cut off. That is the whole logic of telogen effluvium: the hair is a luxury and the body knows it.

Three things in a suppressed appetite push hardest.

Protein. Hair is structural protein. Sustained low intake is a documented contributor to shedding, and protein is the first thing to disappear from a plate when nobody is hungry. In a study of sixty people on these drugs, one in ten reached 1.6 g per kg a day. How to actually reach it is its own problem.

Iron. Depleted iron stores are one of the better-established nutritional associations with diffuse hair loss, particularly in women, who are also the group disproportionately reporting this on GLP-1 drugs. The cross-sectional survey of current users found iron intake below reference levels.

The number people ask for here is ferritin, and there is no agreed cut-off, which is itself worth knowing. Dermatologists who treat hair loss often work to a higher ferritin than the general reference range, so a result a general practitioner calls normal is not always the end of the conversation. What level is right for you is a clinical decision, which is why no number appears on this site.

Zinc. Same survey, same direction, and zinc deficiency has its own well-described hair presentation.

And above all three sits the rate of loss itself. A body dropping weight slowly enough is not being asked to ration, and does not shed.

What I would not tell you

The evidence here is weaker than the confidence with which it gets discussed, including by people selling supplements for it.

A scoping review through May 2025 found nine studies. Most had no dermatological diagnostic confirmation at all, and only one described the clinical pattern. Over a thousand spontaneous case reports exist in the United States, which sounds like a lot until you remember how many millions of prescriptions sit underneath them. The FDA first flagged alopecia as a potential signal in its quarterly report for July to September 2023, and the labelling for semaglutide and tirzepatide was updated to include it between December 2024 and May 2025.

There is also a curiosity in the literature that nobody writing about this mentions. A handful of case reports describe the opposite: improvement and regrowth on tirzepatide, titrated from 2.5 to 7.5 mg weekly, in patients who had other things wrong with their scalps.

I want to be careful about the weight of that. Individual case reports sitting against thousands of adverse event filings is not a balanced argument, and I am not going to present it as one. It is a loose thread worth knowing exists, not a counterweight.

Proposed mechanisms beyond the nutritional ones include IGF-1 signalling disruption, activation of the stress axis, and androgen-mediated pathways unmasking a pattern baldness that was coming anyway. None of these is settled.

The precedent nobody cites

This is not new and it is not specific to these drugs.

Bariatric surgery has produced the same picture for decades, to the point where it has its own name in the case literature. Rapid weight loss, delayed diffuse shedding, and a nutritional component running underneath it. Anybody treating GLP-1 hair loss as a novel pharmacological mystery has not read the surgical literature, where the same problem was described, argued about and largely managed long before semaglutide existed.

The useful part of that precedent is what it implies. Where the surgical teams got ahead of it, they did it with protein targets, commonly 60 to 80 g a day or 1.0 to 1.5 g per kg of ideal bodyweight, alongside routine monitoring and repletion of iron, zinc, B12, folate and vitamin D. Nothing applied to the scalp.

What I do about it

I am a nutritionist. Minoxidil, topical or oral, currently carries the strongest evidence among the follicle-directed treatments, and whether you use it is a conversation with a doctor and not with me.

What sits in my half of the problem:

• Protein first, always. It is the single most common shortfall and the one most plausibly connected to the follicle.
• Iron and zinc checked rather than guessed. Supplementing iron without measuring it is a bad idea in both directions, and the measurement is cheap.
• Rate of loss as a lever. This is the uncomfortable one. If the shedding is driven by speed, then slowing the descent is an intervention, and it is a conversation to have with whoever prescribed the drug rather than a decision to make alone.
• Weekly body composition. Hair is a visible symptom of the same rationing that quietly takes lean tissue. The person shedding is often the person whose scan is going the wrong way, and one of those two things is measurable before it becomes obvious.

If you are in the middle of it

The hair you are finding on the pillow was already lost, months ago, in a decision your body made without asking. Nothing you do this week changes what is already in the resting phase.

What you can change is whether the next round of follicles gets the same instruction. That is decided at the table, over the next few months, and it is entirely unglamorous: enough protein, enough iron, enough zinc, and a rate of loss the body is not treating as an emergency.